Literature DB >> 7203484

Genetic heterogeneity of Fanconi's anemia demonstrated by somatic cell hybrids.

S Zakrzewski, K Sperling.   

Abstract

Cells of patients with Fanconi's anemia (FA) are characterized by their high mitomycin C sensitivity. This specific response was used to study the question of heterogeneity in cell hybrids. After fusion of somatic cells of different FA patients and a normal control, the resulting hybrids were cytogenetically analyzed with respect to their mitomycin C susceptibility. Complementation--indicating heterogeneity--should lead to normal amounts of mitomycin C-induced chromosomal damage. No complementation was found in hybrids between cells of a classical FA patient and one without skeletal malformations. However, clear evidence for heterogeneity was observed in hybrids between cells of the latter patient with early onset and another with late onset of the disease. This confirms the assumption of Schroeder and coworkers based on the high intrafamilial correlation for age at onset.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7203484     DOI: 10.1007/bf00281573

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  CHROMOSOMAL BREAKAGE IN A RARE AND PROBABLY GENETICALLY DETERMINED SYNDROME OF MAN.

Authors:  J GERMAN; R ARCHIBALD; D BLOOM
Journal:  Science       Date:  1965-04-23       Impact factor: 47.728

2.  Deficiency of gamma-ray excision repair in skin fibroblasts from patients with Fanconi's anemia.

Authors:  J F Remsen; P A Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

3.  Normalisation of sister chromatid exchange frequencies in Bloom's syndrome by euploid cell hybridisation.

Authors:  E M Bryant; H Hoehn; G M Martin
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

4.  Genetic complementation after fusion of Tay-Sachs and Sandhoff cells.

Authors:  G H Thomas; H A Taylor; C S Miller; J Axelman; B R Migeon
Journal:  Nature       Date:  1974-08-16       Impact factor: 49.962

5.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

6.  Deficiency of DNA ligase activity in Fanconi's anemia.

Authors:  M Hirsch-Kauffmann; M Schweiger; E F Wagner; K Sperling
Journal:  Hum Genet       Date:  1978-11-24       Impact factor: 4.132

7.  Suppression of spontaneous and mitomycin C-induced chromosome aberrations in Fanconi's anemia by cell fusion with normal human fibroblasts.

Authors:  M C Yoshida
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

8.  [Cytogenetic finding and etiology of Fanconi's anemia. A case of Fanconi's anemia without hexokinase deficiency].

Authors:  T M Schroeder
Journal:  Humangenetik       Date:  1966

9.  Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects.

Authors:  G Fanconi
Journal:  Semin Hematol       Date:  1967-07       Impact factor: 3.851

10.  Genetic complementation studies of multiple sulfatase deficiency.

Authors:  A L Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

View more
  18 in total

1.  Tumor cell complementation groups based on myogenic potential: evidence for inactivation of loci required for basic helix-loop-helix protein activity.

Authors:  A N Gerber; S J Tapscott
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

2.  Noncomplementation of radiation-induced chromosome aberrations in ataxia-telangiectasia/ataxia-telangiectasia-variant heterodikaryons.

Authors:  M Stumm; K Sperling; R D Wegner
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3.  Fanconi's anaemia: correlation of genetic complementation group with psoralen/UVA response.

Authors:  M Digweed; S Zakrzewski-Lüdcke; K Sperling
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

4.  Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene.

Authors:  M Digweed; U Günthert; R Schneider; H Seyschab; R Friedl; K Sperling
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

5.  Complementation studies between Fanconi's anemia cells with different DNA repair characteristics.

Authors:  S Zakrzewski; M Koch; K Sperling
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  Intracellular distribution of DNA topoisomerase I in fibroblasts from patients with Fanconi's anaemia.

Authors:  B Auer; H P Vosberg; U Buhre; H Klocker; M Hirsch-Kauffmann; M Schweiger
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Heterozygous carriers for Bloom syndrome exhibit a spontaneously increased micronucleus formation in cultured fibroblasts.

Authors:  B Frorath; U Schmidt-Preuss; U Siemers; M Zöllner; H W Rüdiger
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Analysis of heterogeneity in Fanconi's anemia patients of different ethnic origin.

Authors:  S Zakrzewski; K Sperling
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  Response of lymphocytes from Fanconi's anemia patients and their heterozygous relatives to 8-methoxy-psoralene in a cloning survival test system.

Authors:  E Wunder; B Fleischer-Reischmann
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

10.  Familial thrombocytopenia associated with platelet autoantibodies and chromosome breakage.

Authors:  F M Helmerhorst; D C Heaton; P E Crossen; A E von dem Borne; C P Engelfriet; A T Natarajan
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.